HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrizia Noris Selected Research

MYH9-Related Disorders

2/2019MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
2/2014MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
1/2013MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations.
1/2012Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.
3/2008Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
1/2003Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome).
4/2002Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrizia Noris Research Topics

Disease

20Thrombocytopenia (Thrombopenia)
01/2022 - 03/2006
11Hemorrhage
01/2022 - 05/2006
7MYH9-Related Disorders
02/2019 - 04/2002
2Cataract (Cataracts)
02/2019 - 11/2005
2Deafness (Deaf Mutism)
02/2019 - 11/2005
2Thrombasthenia (Glanzmann Thrombasthenia)
08/2015 - 05/2009
2Neoplasms (Cancer)
06/2015 - 02/2013
2Bernard-Soulier Syndrome (Giant Platelet Syndrome)
09/2014 - 03/2011
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
07/2013 - 02/2013
2acquired Thrombotic thrombocytopenic purpura
08/2011 - 06/2010
2Thrombotic Thrombocytopenic Purpura
08/2011 - 06/2010
2Glomerulonephritis
11/2005 - 01/2003
1Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
08/2015
1Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
08/2015
1Thrombocytopenia chromosome breakage
02/2014
1Leukemia
02/2014
1Cytopenia
02/2013
1Gastritis
02/2013
1Neutropenia
02/2013
1Inborn Genetic Diseases (Disease, Hereditary)
02/2013
1Hemolytic Anemia
08/2011
1Thrombotic Microangiopathies
08/2011
1Thrombosis (Thrombus)
08/2011
1Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2009
1Thrombocytosis (Thrombocythemia)
12/2007
1Bone Marrow Failure Disorders
09/2007
1Congenital amegakaryocytic thrombocytopenia
09/2007
1Pancytopenia
09/2007
1von Willebrand Diseases (von Willebrand's Disease)
05/2006
1Thrombocytopenia 1
01/2004
1Thalassemia
01/2004
1Dyserythropoietic Anemia with Thrombocytopenia
01/2004
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2003
1Renal Insufficiency (Renal Failure)
01/2003
1Proteinuria
01/2003
1Inflammation (Inflammations)
06/2002

Drug/Important Bio-Agent (IBA)

7Thrombopoietin (c-mpl Ligand)IBA
01/2020 - 09/2007
4Myosin Heavy Chains (Myosin Heavy Chain)IBA
02/2019 - 11/2005
4Nonmuscle Myosin Type IIAIBA
01/2013 - 04/2002
3EnzymesIBA
01/2022 - 01/2012
3von Willebrand FactorIBA
09/2014 - 05/2006
35' Untranslated Regions (5' UTR)IBA
02/2014 - 01/2011
2Transcription Factors (Transcription Factor)IBA
01/2022 - 10/2012
2Adenosine Diphosphate (ADP)IBA
01/2022 - 06/2002
2eltrombopagFDA Link
01/2020 - 12/2010
2Hemostatics (Antihemorrhagics)IBA
01/2020 - 01/2017
2Proteasome Endopeptidase Complex (Proteasome)IBA
06/2015 - 02/2013
2UbiquitinIBA
06/2015 - 02/2013
2Proteins (Proteins, Gene)FDA Link
06/2015 - 02/2013
2thiamine triphosphorate (TTP)IBA
08/2011 - 06/2010
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2020
1CollagenIBA
01/2019
1convulxinIBA
01/2019
1Fibrinogen (Factor I)FDA Link
11/2016
1Prostaglandin H2 Thromboxane A2 ReceptorsIBA
08/2015
1NucleotidesIBA
05/2015
1ActininIBA
01/2015
1Inosine Triphosphate (ITP)IBA
07/2013
1DiamondIBA
02/2013
1Dronabinol (THC)FDA LinkGeneric
10/2012
1ThrombospondinsIBA
08/2011
1AutoantibodiesIBA
08/2011
1Investigational DrugsIBA
08/2011
1Metalloproteases (Metalloproteinases)IBA
08/2011
1DisintegrinsIBA
08/2011
1Thrombopoietin ReceptorsIBA
12/2010
1MethylprednisoloneFDA LinkGeneric
06/2010
1IntegrinsIBA
05/2009
1Platelet Glycoprotein GPIIb-IIIa ComplexIBA
05/2009
1BuffersIBA
03/2009
1Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2007
1Interleukin-6 (Interleukin 6)IBA
12/2007
1Hormones (Hormone)IBA
12/2007
1CytokinesIBA
09/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007
1InterferonsIBA
09/2007
1Biological ProductsIBA
09/2007
1Glycoproteins (Glycoprotein)IBA
03/2006
1Integrin alpha2IBA
03/2006
1DNA (Deoxyribonucleic Acid)IBA
01/2004
1NPHS2 proteinIBA
01/2003
1cerivastatin (Kazak)FDA Link
06/2002
1Simvastatin (Zocor)FDA LinkGeneric
06/2002
1Adenosine Triphosphate (ATP)IBA
06/2002
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2002

Therapy/Procedure

3Platelet Transfusion (Blood Platelet Transfusions)
01/2020 - 12/2010
2Blood Transfusion (Blood Transfusions)
08/2015 - 08/2014
2Therapeutics
03/2013 - 06/2010
1Precision Medicine
02/2015
1Hysterectomy
08/2014
1Plasma Exchange
06/2010